NAVOXIMOD
UNII 926SHL95NC

Substance Identification & Data

This profile provides standardized clinical and technical data for Navoximod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 926SHL95NC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1402837-78-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

926SHL95NC

CAS Registry Number

1402837-78-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAVOXIMOD

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H21FN2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YGACXVRLDHEXKY-WXRXAMBDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C113793

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

70914230

Unique identification number in the NCBI database of chemical substances.

INN ID

10392

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-77

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C([C@H]1c2c(-c3n1cnc3)cccc2F)[C@@H](O)[C@]4(CC[C@@H](CC4)O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Navoximod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.